VMS Pharmaceuticals Private Limited

VMS Pharmaceuticals Private Limited - chemicals in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
CIN U24110MH2015PTC263186 Incorporated 30 March 2015 ROC Mumbai HQ Nagpur, Maharashtra, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2025
₹1.03 Cr
▲ 17% YoY
Net profit · FY 2025
₹2.58 Lakh
Net margin 2.5%
EBITDA · FY 2025
₹9.53 Lakh
EBITDA margin 9.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7 Lakh
Issued & subscribed
Open charges
₹14.68 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings

About VMS Pharmaceuticals Private Limited

Data last updated:

VMS Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 30 March 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2015PTC263186. Its GSTIN is 27AAFCV1409C1ZP (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors including Devendra Sheshrao Thakre and Neeta Devendra Thakre.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Abhijeet Mension 6 Plot No 4 Jetwan Society Shastri Layout, Nagpur, Maharashtra, India – 440022.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.03 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹2.58 Lakh (net margin 2.5%) and EBITDA of ₹9.53 Lakh (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 9% over five years.

As per MCA filings, the company has open charges of ₹14.68 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of VMS Pharmaceuticals Private Limited
CIN U24110MH2015PTC263186
Registration Number 263186
Incorporation Date 30 March 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Abhijeet Mension 6 Plot No 4 Jetwan Society Shastri Layout, Nagpur, Maharashtra, India – 440022
  • Industry
    Chemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
Comprehensive company report
VMS Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full VMS Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for VMS Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of VMS Pharmaceuticals Private Limited

The main business activity of VMS Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of VMS Pharmaceuticals Private Limited FY 2025 filings available

VMS Pharmaceuticals Private Limited reported revenue of ₹1.03 Cr (up 17% YoY) for FY 2025.

Revenue · FY 2025
₹1.03 Cr ▲ 17%
Net profit · FY 2025
₹2.58 Lakh margin 2.5%
EBITDA · FY 2025
₹9.53 Lakh margin 9.3%

Compounded Annual Growth Rate (CAGR) of VMS Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 16%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 18%
5 years · compounded
▲ 27%

Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 17% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of VMS Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹9.53 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹2.58 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of VMS Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.3%••••••••••••••••
Net Profit Margin2.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of VMS Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of VMS Pharmaceuticals Private Limited

VMS Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sunlife Pharmaceuticals Limited••••••••••••••••11Kalyan, Maharashtra, India
Vags Pharmaceuticals Private Limited••••••••••••••••-Meerut, Uttar Pradesh, India
Docmark Pharmaceuticals Private Limited••••••••••••••••-Madurai South, Tamil Nadu, India
Next Era Pharmaceuticals Private Limited••••••••••••••••-Indore, Madhya Pradesh, India
Amazeen Pharmaceuticals Private Limited••••••••••••••••-New Delhi, Delhi, India
VMS Pharmaceuticals Private Limited this company••••••••••••••••-Nagpur, Maharashtra, India
Wiliance Pharmaceuticals Private Limited••••••••••••••••-Huzur, Madhya Pradesh, India
Virtus Pharmaceuticals Private Limited••••••••••••••••-Hyderabad, Telangana, India
Velliq Pharmaceuticals Private Limited••••••••••••••••-Hyderabad, Telangana, India
C W C Pharmaceuticals Pvt. Ltd.••••••••••••••••-Haryana, India
Endurable Pharmaceuticals Private Limited••••••••••••••••-Vapi, Gujarat, India

Peers are the five companies nearest above and the five nearest below VMS Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of VMS Pharmaceuticals Private Limited

VMS Pharmaceuticals Private Limited is audited by RAHUL KATARIYA & ASSOCIATES for the financial year 2017.

NameStatusAppointment DateCessation Date
RAHUL KATARIYA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of VMS Pharmaceuticals Private Limited

VMS Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Devendra Sheshrao ThakreDirector30 Mar 201511 Years 6 MonthsCurrent
Neeta Devendra ThakreDirector04 Jul 20251 Years 3 MonthsCurrent
Nitin Dattuji WasankarDirector04 Jul 20251 Years 3 MonthsCurrent

Ownership and Shareholding of VMS Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of VMS Pharmaceuticals Private Limited

Open charges
₹14.68 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.15 Cr
Latest charge details
DateLenderAmountStatus
17 Mar 2020Others₹14.68 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at VMS Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to VMS Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on VMS Pharmaceuticals Private Limited

VMS Pharmaceuticals Private Limited has 5 board changes on record since 2015: 3 appointments and 2 cessations. The latest: Kailash Madhukar Mane ceased to be Director on 04 Jul 2025.

AGM
Vms Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Kailash Madhukar Mane ceased to be Director.
Appointed
Neeta Devendra Thakre was appointed as Director.
Appointed
Nitin Dattuji Wasankar was appointed as Director.
Filing
Vms Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 14.68 Lakh with Charge ID 100393956 was registered on 17 Mar 2020.
Ceased
Suwarna Ramdas Deshmukh ceased to be Additional Director.
Appointed
Devendra Sheshrao Thakre was appointed as Director.
Incorporation
30 Mar 2015
Vms Pharmaceuticals Private Limited was registered on 30 Mar 2015 with Roc Mumbai & aged 11 years 6 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for VMS Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by VMS Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of VMS Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of VMS Pharmaceuticals Private Limited

VMS Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAFCV1409C1ZPMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of VMS Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about VMS Pharmaceuticals Private Limited

VMS Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 30 March 2015 (11+ years old) and is registered under CIN U24110MH2015PTC263186.

VMS Pharmaceuticals reported revenue of ₹1.03 Cr for FY 2025 (up 17% YoY).

VMS Pharmaceuticals has 3 current directors:

VMS Pharmaceuticals reported a net profit of ₹2.58 Lakh (net margin 2.5%) and EBITDA of ₹9.53 Lakh (EBITDA margin 9.3%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of VMS Pharmaceuticals is 16% over three years and 9% over five years. In the latest year (FY 2025) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of VMS Pharmaceuticals is 27AAFCV1409C1ZP, registered in Maharashtra.

The CIN (Corporate Identification Number) of VMS Pharmaceuticals is U24110MH2015PTC263186. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

VMS Pharmaceuticals was incorporated on 30 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of VMS Pharmaceuticals by revenue are Sunlife Pharmaceuticals Limited, Vags Pharmaceuticals Private Limited, Docmark Pharmaceuticals Private Limited, Next Era Pharmaceuticals Private Limited, Amazeen Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Kailash Madhukar Mane ceased to be Director on 04 Jul 2025. Neeta Devendra Thakre was appointed as Director on 04 Jul 2025. Nitin Dattuji Wasankar was appointed as Director on 04 Jul 2025. VMS Pharmaceuticals has 5 board changes on record in total.

The registered office of VMS Pharmaceuticals is at Abhijeet Mension 6 Plot No 4 Jetwan Society Shastri Layout, Nagpur, Maharashtra, India – 440022.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available